Achieve announces patent granted in the u.s. for novel analogs of cytisinicline for use in cns and addiction indications

Seattle and vancouver, british columbia, july 31, 2020 /prnewswire/ -- achieve life sciences, inc. (nasdaq: achv), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that the united.
ACHV Ratings Summary
ACHV Quant Ranking